MSD & GSK only brought dishonor on NIP over their cervical cancer vaccines
The pharmaceutical companies which delayed the enforcement day to raise profits on the NIP project with cervical cancer vaccines did not earn substance, but only brought dishonor.
This is because the unit prices bid at the Public Procurement Service for the NIP on ‘Gardasil’ and ‘Cervarix’ did n...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
